Second Phase of the NIH Preprint Pilot Launched

Today, we are pleased to announce the launch of the second phase of the NIH Preprint Pilot with the addition of more than 700 new preprint records to PubMed Central (PMC) and PubMed. This second phase expands the scope of the Pilot to include preprints resulting from all NIH-funded research. Eligible preprints are those acknowledging direct support of an NIH award or authored by NIH staff and posted to bioRxiv, medRxiv, arXiv, or Research Square, on or after January 1, 2023. NLM will automatically include the full text of the preprint (as license terms allow) and associated citation information in PMC and PubMed, respectively. New preprint records will be added on a weekly basis. Phase 2 of the pilot is expected to run through 2023. A project of NLM, the NIH Preprint Pilot was launched in 2020 to explore new approaches to increase the discoverability of NIH-supported research results, with the first phase focusing on NIH-supported research on COVID-19 and the SARS-CoV-2 virus. To learn more, visit the NIH Preprint Pilot page.